Atlas Trials

Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer

Clinical trial NCT00696579 · COMPLETED

Trial details

NCT number
NCT00696579
Sponsor
University Of Perugia
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2004-01-01
Primary completion
2008-03-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.